Binding of [3H] (2S,1′S,2′S)-2-(9-xanthylmethyl)-2-(2′-carboxycycloprophyl) glycine ([3H]LY341495) to cell membranes expressing recombinant human group III metabotropic glutamate receptor subtypes

被引:48
作者
Wright, RA [1 ]
Arnold, MB [1 ]
Wheeler, WJ [1 ]
Ornstein, PL [1 ]
Schoepp, DD [1 ]
机构
[1] Eli Lilly & Co, Lilly Corp Ctr, Lilly Res Labs, Indianapolis, IN 46285 USA
关键词
LY341495; metabotropic glutamate receptors; group III mGlu receptors; radioligand; receptor binding;
D O I
10.1007/s002100000305
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
LY341495 is a highly potent and selective antagonist for group II mGlu receptors (mGlu2 and mGglu3). High affinity binding of [H-3]LY341495 to recombinant human group II mGlu receptors (mGlu2 and mGlu3), and in rat brain homogenates (K-d similar to 1 nM), has been previously described. Although LY341495 is a very selective nM-potent antagonist for group II mGlu receptors, it is also a relatively potent antagonist for group III mGlu receptors at high nanomolar to low micromolar concentrations. In this study we examined and characterized the binding of [H-3]LY341495 to membranes of cells expressing recombinant human group III mGlu receptors. Using up to 100 nM of [H-3]LY341495, the level of specific binding in human mGlu4a receptor-expressing cell membranes was not appreciable and binding to this site was not examined further. In contrast, we demonstrated sufficient specific binding of [H-3]LY341495 to human mGlu6, mGlu7a and mGlu8a receptor-expressing cell membranes to allow for further characterizations. [H-3]LY341495 binding was saturable and rapidly reversible. [H-3]LY341495 bound to a single site in each cell line, with K-d and B-max values of 31.6+/-6.8 nM and 3.3+/-0.7 pmol/mg protein (mGlu6), 72.7+/-22.0 nM and 3.7+/-0.4 pmol/mg protein (mGlu8a), and 14.0+/-1.1 nM and 3.0+/-0.2 pmol/mg protein (mGlu8a), [H-3]LY341495 binding to mGlu6, 7a and 7a was displaceable by compounds which interact functionally with group III mGlu receptors. For example, L-AP4 displaced [H-3]LY341495 with Ki values of 6.8+/-3.1 muM (mGlu6), 211+/-43 muM (mGlu7a) and 1.6+/-0.3 muM (mGlu8a). With L-glutamate, we obtained K-i values of 12.3+/-3.5, 869+/-154 and 4.5+/-0.83 muM, for mGlu6, mGlu7a and mGlu8a, respectively. K-i values for unlabelled LY341495 were 0.058+/-0.008, 0.22+/-0.05 and 0.029+/-0.008 muM, respectively. These studies demonstrated that [H-3]LY341495 is a useful radioligand for studying the pharmacology and expression of recombinant mGlu6, 7a and 8a receptors in cell lines.
引用
收藏
页码:546 / 554
页数:9
相关论文
共 39 条
[31]   A FAMILY OF METABOTROPIC GLUTAMATE RECEPTORS [J].
TANABE, Y ;
MASU, M ;
ISHII, T ;
SHIGEMOTO, R ;
NAKANISHI, S .
NEURON, 1992, 8 (01) :169-179
[32]  
Thomas NK, 1996, NEUROPHARMACOLOGY, V35, P637
[33]   The L-AP4 receptor [J].
Thomsen, C .
GENERAL PHARMACOLOGY, 1997, 29 (02) :151-158
[34]   The effects of (RS)-alpha-cyclopropyl-4-phosphonophenylglycine ((RS)-CPPG), a potent and selective metabotropic glutamate receptor antagonist [J].
Toms, NJ ;
Jane, DE ;
Kemp, MC ;
Bedingfield, JS ;
Roberts, PJ .
BRITISH JOURNAL OF PHARMACOLOGY, 1996, 119 (05) :851-854
[35]   (2S,4S)-2-amino-4-(4,4-diphenylbut-1-yl)-pentane-1,5-dioic acid: A potent and selective antagonist for metabotropic glutamate receptors negatively linked to adenylate cyclase [J].
Wermuth, CG ;
Mann, A ;
Schoenfelder, A ;
Wright, RA ;
Johnson, BG ;
Burnett, JP ;
Mayne, NG ;
Schoepp, DD .
JOURNAL OF MEDICINAL CHEMISTRY, 1996, 39 (04) :814-816
[36]  
WRIGHT RA, 1994, J NEUROCHEM, V63, P938
[37]  
Wright RA, 1999, NEUROPHARMACOLOGY, V38, pA47
[38]  
Wroblewska B, 1997, J NEUROCHEM, V69, P174
[39]   Group III human metabotropic glutamate receptors 4, 7 and 8: Molecular cloning, functional expression, and comparison of pharmacological properties in RGT cells [J].
Wu, S ;
Wright, RA ;
Rockey, PK ;
Burgett, SG ;
Arnold, JS ;
Rosteck, PR ;
Johnson, BG ;
Schoepp, DD ;
Belagaje, RM .
MOLECULAR BRAIN RESEARCH, 1998, 53 (1-2) :88-97